Brief: Vascular Biogenics Applies To Transfer Listing Of Its Ordinary Shares

Notable Labs

01/03/2023 14:31

March 1 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VASCULAR BIOGENICS LTD - ON FEB 21, VBL APPLIED TO
TRANSFER
LISTING OF ITS ORDINARY SHARES FROM NASDAQ GLOBAL MARKET TO
NASDAQ CAPITAL MARKET
    * VASCULAR BIOGENICS - ON FEB 28, VBL RECEIVED CONFIRMATION
THAT
NASDAQ HAD APPROVED THE TRANSFER
    * VASCULAR BIOGENICS LTD - VBL'S ORDINARY SHARES WILL BEGIN
TRADING ON NASDAQ CAPITAL MARKET EFFECTIVE WITH OPEN OF TRADING
ON MARCH 2, 2023
    * VASCULAR BIOGENICS LTD - VBL'S ORDINARY SHARES CONTINUE TO
TRADE
UNDER SYMBOL "VBLT"
    * VASCULAR BIOGENICS - ON FEB 28, NASDAQ DETERMINED VBL IS
ELIGIBLE FOR ADDITIONAL 180-CALENDAR DAY PERIOD, OR UNTIL AUG
28, 2023, TO REGAIN COMPLIANCE

Further company coverage:  VBLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))